Suppr超能文献

CD15免疫染色在霍奇金淋巴瘤诊断中的价值:已发表文献综述

Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature.

作者信息

Hall P A, D'Ardenne A J

机构信息

Department of Histopathology, St Bartholomew's Hospital, London.

出版信息

J Clin Pathol. 1987 Nov;40(11):1298-304. doi: 10.1136/jcp.40.11.1298.

Abstract

The role of antibodies of CD15 as diagnostic markers of Hodgkin's disease was assessed from a review of the literature. A total of 571 cases of Hodgkin's disease and 386 cases of non-Hodgkin's lymphoma were included. The sensitivity of CD15 in detecting cases of Hodgkin's disease was 80% or 91% if cases of lymphocyte predominant Hodgkin's disease were excluded. The specificity of CD15 was only 80.6%, or in other words, 19.4% of cases of non-Hodgkin's lymphoma were CD15 positive. In an ideal test both the sensitivity and specificity would be 100% and if the test performance were no better than chance then they would both be 50%. It is concluded that CD15 immunostaining cannot be regarded as a sensitive or specific marker of Hodgkin's disease. Application of this formal method of analysis to other immunohistological reagents and panels of antibodies is discussed.

摘要

通过文献综述评估了CD15抗体作为霍奇金病诊断标志物的作用。共纳入571例霍奇金病病例和386例非霍奇金淋巴瘤病例。如果排除淋巴细胞为主型霍奇金病病例,CD15检测霍奇金病病例的敏感性为80%或91%。CD15的特异性仅为80.6%,换言之,19.4%的非霍奇金淋巴瘤病例CD15呈阳性。在理想的检测中,敏感性和特异性均应为100%,如果检测性能不比随机情况更好,那么两者均应为50%。结论是,CD15免疫染色不能被视为霍奇金病的敏感或特异性标志物。讨论了将这种正式分析方法应用于其他免疫组织化学试剂和抗体组合的情况。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验